Navigation Links
China Biologic Products Announces Third Quarter 2008 Results Conference Call
Date:11/11/2008

TAI'AN CITY, Shandong, China, Nov. 11 /Xinhua-PRNewswire-FirstCall/ -- China Biologic Products, Inc. (OTC Bulletin Board: CBPO) ("CBP," or the "Company"), one of the leading plasma-based pharmaceutical companies in the People's Republic of China ("PRC"), today announced that it will host a conference call at 10:00 a.m. EST on Thursday, November 13, 2008, to discuss the third quarter 2008 results.

Hosting the call will be Mr. Colin Zhao, Chief Executive Officer, and Mr. Tristan Kuo, Chief Financial Officer. The Company plans to release its earnings on November 12, 2008.

To participate in the live conference call, please dial the following number five to ten minutes prior to the scheduled conference call time: 888- 339-2688. International callers should dial 617-847-3007. The pass code for the call is 320 762 60.

If you are unable to participate in the call at this time, a replay will be available for 14 days starting on Thursday, November 13, 2008 at 12:00 p.m. EST. To access the replay, dial 888-286-8010, international callers should dial 617-801-6888. The conference pass code is 14755104.

About China Biologic Products, Inc.

Through its indirect majority-owned subsidiary Shandong Taibang Biological Products Co. Ltd., China Biologic Products, Inc. (the "Company"), is principally engaged in the research, development, production and sale of plasma-based biopharmaceutical products to hospitals and other health care facilities in China. The Company's human albumin products are mainly used to increase blood volume, and its immunoglobulin products are used for the treatment and prevention of diseases.

For more information, please contact:

Company Contact:

Mr. Y. Tristan Kuo

CFO

China Biologic Products, Inc.

Tel: +86-538-620-2206

Email: IR@chinabiologic.com

Web: http://www.chinabiologic.com

Investor Relations Contact:

Mr. Crocker Coulson

President

CCG Investor Relations

Tel: +1-646-213-1915 (NY office)

Email: crocker.coulson@ccgir.com

Web: http://www.ccgirasia.com


'/>"/>
SOURCE China Biologic Products, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. China-Biotics, Inc. Reports Second Quarter 2009 Financial Results
2. China Clean Energy Resumes Biodiesel Production After Temporary Halt
3. China Medicine Announces Conference Call to Discuss Third Quarter 2008 Results
4. Yongye Biotechnology to Present at Roth Capital China Comes to Vegas Conference
5. China Sky One Medical, Inc. Announces Conference Call to Discuss Third Quarter 2008 Results
6. China Pharma Holdings, Inc. to Present at Two Upcoming U.S. Investor Conferences
7. China Yingxia to Present at Roth China Comes to Vegas Conference
8. PAREXEL Expert to Address Key Aspects of Conducting Clinical Trials in China at 7th Annual Partnerships in Clinical Trials Congress
9. Sinovac Named to Deloitte Technology Fast 50 China
10. Sundia MediTech Ranked #16 in Deloitte Technology Fast 50 China
11. China Medical Technologies Announces Reporting Dates for the September Quarter Results and Addresses Investor Inquiries
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016  The Prostate Cancer Foundation (PCF) is ... treatments and faster cures for prostate cancer. Members of the Class of 2016 ... countries. Read More About the Class of 2016 PCF ... ... ...
(Date:6/23/2016)... ... 23, 2016 , ... Supplyframe, the Industry Network for electronics ... Lab . Located in Pasadena, Calif., the Design Lab’s mission is to bring ... designed, built and brought to market. , The Design Lab is Supplyframe’s physical ...
(Date:6/23/2016)... , June 23, 2016 Apellis ... Phase 1 clinical trials of its complement C3 ... single and multiple ascending dose studies designed to ... (PD) of subcutaneous injection in healthy adult volunteers. ... (SC) either as a single dose (ranging from ...
(Date:6/23/2016)... NEW YORK , June 23, 2016 ... the trading session at 4,833.32, down 0.22%; the Dow Jones ... the S&P 500 closed at 2,085.45, down 0.17%. Stock-Callers.com has ... INFI ), Nektar Therapeutics (NASDAQ: NKTR ... BIND Therapeutics Inc. (NASDAQ: BIND ). Learn more ...
Breaking Biology Technology:
(Date:6/22/2016)... , June 22, 2016 On Monday, ... call to industry to share solutions for the Biometric ... U.S. Customs and Border Protection (CBP), explains that CBP ... are departing the United States , ... and to defeat imposters. Logo - ...
(Date:6/16/2016)... 16, 2016 The global ... to reach USD 1.83 billion by 2024, according ... Inc. Technological proliferation and increasing demand in commercial ... to drive the market growth.      ... The development of advanced multimodal techniques for biometric ...
(Date:6/9/2016)... , June 9, 2016 ... Police deploy Teleste,s video security solution to ensure the safety ... France during the major tournament Teleste, ... communications systems and services, announced today that its video security ... to back up public safety across the country. ...
Breaking Biology News(10 mins):